ClinicalTrials.Veeva

Menu

Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis

A

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Status

Completed

Conditions

Supraspinatus Tendinitis

Treatments

Procedure: one-shot PRP injection

Study type

Observational

Funder types

Other

Identifiers

NCT04851951
PRP-shoulder

Details and patient eligibility

About

It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection), T2 (three months after the last injection) and T3 (six months after the last injection).

Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue Scale (VAS) were administered at each evaluation.

Enrollment

48 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years old;
  • Supraspinatus tendinosis detected by MRI.

Exclusion criteria

  • Supraspinatus rupture;
  • Previous shoulder surgery;
  • Rotator cuff tears secondary to fracture;
  • Hemoglobin <7 g/dL or Platelets < 30,000 microL;
  • Active infection;
  • Pregnant patients;
  • Patients with hematologic and oncologic diseases.

Trial design

48 participants in 1 patient group

patients treated by one-shot PRP injection
Treatment:
Procedure: one-shot PRP injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems